P41 Contact allergy to clindamycin
A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Sinovich, Vania [verfasserIn] Powell, S [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK; Malden, USA: Blackwell Science Ltd/Inc. ; 2004 |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2008 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: Contact dermatitis - Oxford [u.a.] : Wiley-Blackwell, 1975, 50(2004), 3, Seite 0 |
| Übergeordnetes Werk: |
volume:50 ; year:2004 ; number:3 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1111/j.0105-1873.2004.0309fw.x |
|---|
| Katalog-ID: |
NLEJ242529712 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ242529712 | ||
| 003 | DE-627 | ||
| 005 | 20210707160444.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s2004 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/j.0105-1873.2004.0309fw.x |2 doi | |
| 035 | |a (DE-627)NLEJ242529712 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Sinovich, Vania |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a P41 Contact allergy to clindamycin |
| 264 | 1 | |a Oxford, UK; Malden, USA |b Blackwell Science Ltd/Inc. |c 2004 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. | ||
| 533 | |d 2008 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2008|||||||||| | ||
| 700 | 1 | |a Powell, S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Contact dermatitis |d Oxford [u.a.] : Wiley-Blackwell, 1975 |g 50(2004), 3, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243927118 |w (DE-600)2027120-7 |x 1600-0536 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2004 |g number:3 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2004 |e 3 |h 0 | ||
| author_variant |
v s vs s p sp |
|---|---|
| matchkey_str |
article:16000536:2004----::4cnatlegtc |
| hierarchy_sort_str |
2004 |
| publishDate |
2004 |
| allfields |
10.1111/j.0105-1873.2004.0309fw.x doi (DE-627)NLEJ242529712 DE-627 ger DE-627 rakwb Sinovich, Vania verfasserin aut P41
Contact allergy to clindamycin Oxford, UK; Malden, USA Blackwell Science Ltd/Inc. 2004 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| Powell, S verfasserin aut In Contact dermatitis Oxford [u.a.] : Wiley-Blackwell, 1975 50(2004), 3, Seite 0 Online-Ressource (DE-627)NLEJ243927118 (DE-600)2027120-7 1600-0536 nnns volume:50 year:2004 number:3 pages:0 http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 50 2004 3 0 |
| spelling |
10.1111/j.0105-1873.2004.0309fw.x doi (DE-627)NLEJ242529712 DE-627 ger DE-627 rakwb Sinovich, Vania verfasserin aut P41
Contact allergy to clindamycin Oxford, UK; Malden, USA Blackwell Science Ltd/Inc. 2004 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| Powell, S verfasserin aut In Contact dermatitis Oxford [u.a.] : Wiley-Blackwell, 1975 50(2004), 3, Seite 0 Online-Ressource (DE-627)NLEJ243927118 (DE-600)2027120-7 1600-0536 nnns volume:50 year:2004 number:3 pages:0 http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 50 2004 3 0 |
| allfields_unstemmed |
10.1111/j.0105-1873.2004.0309fw.x doi (DE-627)NLEJ242529712 DE-627 ger DE-627 rakwb Sinovich, Vania verfasserin aut P41
Contact allergy to clindamycin Oxford, UK; Malden, USA Blackwell Science Ltd/Inc. 2004 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| Powell, S verfasserin aut In Contact dermatitis Oxford [u.a.] : Wiley-Blackwell, 1975 50(2004), 3, Seite 0 Online-Ressource (DE-627)NLEJ243927118 (DE-600)2027120-7 1600-0536 nnns volume:50 year:2004 number:3 pages:0 http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 50 2004 3 0 |
| allfieldsGer |
10.1111/j.0105-1873.2004.0309fw.x doi (DE-627)NLEJ242529712 DE-627 ger DE-627 rakwb Sinovich, Vania verfasserin aut P41
Contact allergy to clindamycin Oxford, UK; Malden, USA Blackwell Science Ltd/Inc. 2004 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| Powell, S verfasserin aut In Contact dermatitis Oxford [u.a.] : Wiley-Blackwell, 1975 50(2004), 3, Seite 0 Online-Ressource (DE-627)NLEJ243927118 (DE-600)2027120-7 1600-0536 nnns volume:50 year:2004 number:3 pages:0 http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 50 2004 3 0 |
| allfieldsSound |
10.1111/j.0105-1873.2004.0309fw.x doi (DE-627)NLEJ242529712 DE-627 ger DE-627 rakwb Sinovich, Vania verfasserin aut P41
Contact allergy to clindamycin Oxford, UK; Malden, USA Blackwell Science Ltd/Inc. 2004 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. 2008 Blackwell Publishing Journal Backfiles 1879-2005 |2008|||||||||| Powell, S verfasserin aut In Contact dermatitis Oxford [u.a.] : Wiley-Blackwell, 1975 50(2004), 3, Seite 0 Online-Ressource (DE-627)NLEJ243927118 (DE-600)2027120-7 1600-0536 nnns volume:50 year:2004 number:3 pages:0 http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 50 2004 3 0 |
| source |
In Contact dermatitis 50(2004), 3, Seite 0 volume:50 year:2004 number:3 pages:0 |
| sourceStr |
In Contact dermatitis 50(2004), 3, Seite 0 volume:50 year:2004 number:3 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| isfreeaccess_bool |
false |
| container_title |
Contact dermatitis |
| authorswithroles_txt_mv |
Sinovich, Vania @@aut@@ Powell, S @@aut@@ |
| publishDateDaySort_date |
2004-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243927118 |
| id |
NLEJ242529712 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242529712</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707160444.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2004 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.0105-1873.2004.0309fw.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242529712</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sinovich, Vania</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P41
Contact allergy to clindamycin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK; Malden, USA</subfield><subfield code="b">Blackwell Science Ltd/Inc.</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2008</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2008||||||||||</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Powell, S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Contact dermatitis</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1975</subfield><subfield code="g">50(2004), 3, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927118</subfield><subfield code="w">(DE-600)2027120-7</subfield><subfield code="x">1600-0536</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2004</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Sinovich, Vania |
| spellingShingle |
Sinovich, Vania P41 Contact allergy to clindamycin |
| authorStr |
Sinovich, Vania |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243927118 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK; Malden, USA |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1600-0536 |
| topic_title |
P41
Contact allergy to clindamycin |
| publisher |
Blackwell Science Ltd/Inc. |
| publisherStr |
Blackwell Science Ltd/Inc. |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| hierarchy_parent_title |
Contact dermatitis |
| hierarchy_parent_id |
NLEJ243927118 |
| hierarchy_top_title |
Contact dermatitis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243927118 (DE-600)2027120-7 |
| title |
P41
Contact allergy to clindamycin |
| ctrlnum |
(DE-627)NLEJ242529712 |
| title_full |
P41
Contact allergy to clindamycin |
| author_sort |
Sinovich, Vania |
| journal |
Contact dermatitis |
| journalStr |
Contact dermatitis |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2004 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Sinovich, Vania Powell, S |
| container_volume |
50 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Sinovich, Vania |
| doi_str_mv |
10.1111/j.0105-1873.2004.0309fw.x |
| author2-role |
verfasserin |
| title_sort |
p41
contact allergy to clindamycin |
| title_auth |
P41
Contact allergy to clindamycin |
| abstract |
A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. |
| abstractGer |
A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. |
| abstract_unstemmed |
A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
3 |
| title_short |
P41
Contact allergy to clindamycin |
| url |
http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x |
| remote_bool |
true |
| author2 |
Powell, S |
| author2Str |
Powell, S |
| ppnlink |
NLEJ243927118 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1111/j.0105-1873.2004.0309fw.x |
| up_date |
2024-07-06T02:18:02.263Z |
| _version_ |
1803794285606207488 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242529712</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707160444.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2004 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.0105-1873.2004.0309fw.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242529712</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sinovich, Vania</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">P41
Contact allergy to clindamycin</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK; Malden, USA</subfield><subfield code="b">Blackwell Science Ltd/Inc.</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A 42-year–old non-atopic lady was treated with twice daily 2% clindamycin vaginal cream (Dalacin®) and ster-zac (bath antiseptic) for hidradenitis of the groins. She also had mild facial acne.She developed genital pruritus and erythema which quickly became generalised which she related to the use of ster-zac. However, when she applied clindamycin to her face a few weeks later, she developed a severe reaction which became generalised.The patient was patch tested with an extended European series, the clindamycin cream, ster-zac 1:100 and E45 which had also been used. Initially she developed an angry back picture which was difficult to assess but the standard testing was negative.Repeat patch testing to the constituents of the topical preparations used produced a reaction to clindamycin 1%, 5% and to dalacin cream ‘as is’. Discussion: Coskey1 first described contact allergy to clindamycin in 1978. Since then there have been 6 further case reports. Mild local adverse reactions to topical clindamycin preparations such as burning, excessive dryness, itching and erythema are not uncommon, but more serious adverse events should prompt exclusion of a contact allergic component. Despite topical clindamycin being used for more than 25 years, sensitisation appears uncommon.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2008</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2008||||||||||</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Powell, S</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Contact dermatitis</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1975</subfield><subfield code="g">50(2004), 3, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243927118</subfield><subfield code="w">(DE-600)2027120-7</subfield><subfield code="x">1600-0536</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2004</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.0105-1873.2004.0309fw.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2004</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.399912 |